Start Codon, located in the heart of the Cambridge Cluster, aims to provide a much-needed world-class life science accelerator that offers significant funding and support to rapidly translate the most disruptive and innovative research into successful start-up companies. Start Codon’s founding investors include Cambridge Innovation Capital, Babraham Research Campus through Babraham Bioscience Technologies, Genentech, a member of the Roche Group, Dr Jonathan Milner and Dr Ian Tomlinson.
27 April, 2019
Medicines Discovery Catapult today announces the launch of twenty-two partnerships with UK contract research organisations (CROs). The aim is to boost UK life sciences R&D and international competitiveness by channelling high quality projects through best-in-class service providers.
26 April, 2019
Pharmacologist Dr Fraser Scott wins Royal Society of Chemistry award for his innovative approach to helping science students succeed in a maths-heavy module
25 April, 2019
The topic of this month’s newsletter from Drug Discovery Today is “Partnerships and Alliances”.
24 April, 2019
Invokana® (canagliflozin) is the only medicine in nearly 20 years and the first diabetes medicine to demonstrate significant reduction in risk of renal failure, dialysis or kidney transplantation and renal or cardiovascular (CV) death in this high-risk population
15 April, 2019